TriviumVet’s felycin®-CA1 has been granted conditional approval by the U.S. Food and Drug Administration (FDA). This marks a significant milestone in feline cardiac care as the...
TriviumVet are delighted to be working with Texas A&M University on this exciting clinical trial. Press Release by Texas A&M University: Dilated cardiomyopathy (DCM) is the second...